HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3',4'-deoxypsorospermin-4'-chloro-3'-ol

isolated from Psorospermum febrifugum; structure given in first source

Also Known As:

DPCO

Networked: 7 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Xanthenes: 65
      - 3',4'-deoxypsorospermin-4'-chloro-3'-ol: 7

Experts

1.	Beijnen, J H: 1 article (07/2015)
2.	Gupta, A: 1 article (07/2015)
3.	Huitema, A D R: 1 article (07/2015)
4.	Hussein, Z: 1 article (07/2015)
5.	Schellens, J H M: 1 article (07/2015)
6.	van Hasselt, J G C: 1 article (07/2015)
7.	Ruokonen, E: 1 article (12/2001)
8.	Tenhunen, J J: 1 article (12/2001)
9.	Uusaro, A: 1 article (12/2001)
10.	Constable, P D: 1 article (09/2001)

Related Diseases

1.	Hypersensitivity (Allergy) 12/20/2022 - "This study aimed to identify and compare allergens in fresh coconut milk (FCM), boiled coconut milk (BCM), unrefined wet-processed coconut oil (WPCO), and dry-processed coconut oil (DPCO) using sera from patients with allergy to coconut milk. "
2.	Fetal Weight 02/01/1983 - "The decrease in placental weight along with the decrease in DPCO per kg of fetal weight suggests that with progressive maternal exercise the fetus is compromised by a smaller than normal placenta with less diffusing capacity."
3.	Sepsis (Septicemia) 12/01/2001 - "We hypothesized that DPCO(2gas) can be used as a semi-continuous indicator of mucosal arterial PCO(2) gradient in sepsis. "
4.	Disease Progression 07/01/2015 - "In oncology, disease progression/clinical outcome (DPCO) models have been used for early predictions of clinical outcome, but most of such approaches did not include adverse events or dose intensity. "
5.	Sudden Infant Death (SID) 09/01/2001 - "The derivatives of pH with respect to the three independent variables [strong ion difference (SID), PCO(2), and A(tot)] of the strong ion approach were calculated as follows: dpH/dSID(+) = [1 + 10(pK(a)-pH)](2)/(2.303 x [SPCO(2)10(pH-pK'(1)[1 + 10(pK(a)-pH](2) + A(tot)10(pK(a)-PH]]; dpH/dPCO(2) = S10(-pK'(1)/[2.303[A(tot)10(pH)(10(pH + 10(pK(a))(-2) - SID(+)10(-pH)]], dpH/dA(tot) = -1/[2.303[SPCO(2)10(pH-pK'(1) + SID(+)10(pK(a)-pH)]], where S is solubility of CO(2) in plasma. "

Related Drugs and Biologics

1.	Allergens
2.	Coconut Oil
3.	Prostate-Specific Antigen (Semenogelase)
4.	Indicators and Reagents (Reagents)

Related Therapies and Procedures

1.	Prostheses and Implants (Prosthesis)